European Markets Move Higher as Growth Fears Remain


By Scott Kanowsky 

Investing.com — European markets moved higher on Friday, adding to momentum from a late rally on Wall Street, but sentiment remains cautious as recent economic data points toward a potential downturn in growth.

As of 04:02 AM EST (0802 GMT), Europe’s index rose 0.87% to 405.90. The in Germany, in France, and Italy’s also increased.

The upticks come as headline fell by more-than-expected to 92.3 in June, according to an Ifo institute survey, pointing to broader pessimism in the manufacturing and service sectors in Europe’s largest economy.

In the U.K., the was also in the green, up 0.87% to 7,081.60, as investors shrugged off a decline in for May. Earlier in the day, also dropped to a record low, with market research firm GfK saying its measure of sentiment dropped 1 point to minus 41 in June.

European equity indices have received a positive handover from the U.S., as the major averages on Wall Street received late buying interest to close with solid gains on Thursday. The move came after Federal Reserve Chair Jerome Powell wrapped up his two-day testimony on the economy in Congress.

See also  Women Not Wearing Hijab ‘Trying to Look Like Animals’, Say Taliban Posters

However, fears persist that aggressive monetary policy tightening by central banks around the world, aimed at curbing a recent surge in inflation, may instead spark a recession. In his testimony, Powell acknowledged that this outcome remains a possibility.

This concern partly led to Zalando SE (ETR:) issuing a second profit warning in two months, which sent shares in the German online fashion retailer sliding to an eight-year low. The company lowered its full-year projections, citing a deterioration in economic conditions.

Elsewhere, Dutch medical equipment provider Koninklijke Philips NV (AS:) and health care firm Merck KGaA (ETR:) were among the top performers in the STOXX 600.

Paris-listed shares in Sanofi SA (EPA:) also jumped after the French drugmaker said its COVID-19 vaccine candidate delivered 72% efficacy in adults against the Omicron strain, citing data gathered in a study.

Meanwhile, futures rose, along with the contract. Both of the benchmarks are on course for their first back-to-back weekly losses since April, as traders try to balance worries over supply uncertainty and sliding demand spurred on by slowing economic growth in the U.S.

Additionally, fell slightly, while traded 0.06% higher at $1.0529.

See also  Florida expands state of emergency to 3 counties affected by wildfires

 



Source link

We will be happy to hear your thoughts

Leave a reply

financetin
Logo
%d bloggers like this:
Shopping cart